Home - Products - MAPK/ERK Signaling - p38 MAPK - methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate

CAS No. 517870-17-6

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate( —— )

Catalog No. M24490 CAS No. 517870-17-6

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate targets MAPK.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 29 In Stock
25MG 51 In Stock
50MG 75 In Stock
100MG 112 In Stock
200MG 168 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate
  • Note
    Research use only, not for human use.
  • Brief Description
    methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate targets MAPK.
  • Description
    methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate targets MAPK.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    MAPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    517870-17-6
  • Formula Weight
    263.25
  • Molecular Formula
    C13H13NO5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    COC1=C(C=C(C=C1)C2=CC(=NO2)C(=O)OC)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BI-2865

    BI-2865 is a none-covalent pan-KRAS Inhibitor. BI-2865 binds to WT, G12C, G12D, G12V and G13D mutant KRAS with KDs of 6.9, 4.5, 32, 26, 4.3 nM respectively.

  • EO-1606

    EO-1606 is a p38MAP kinase inhibitor with anti-inflammatory activity and may be used in studies of Alzheimer;s disease and dermatitis.

  • AMG-548

    AMG-548 is a potent and selective inhibitor of p38α with Ki of 0.5 nM, dispalys weak inhibition for p38β (Ki=3.6 nM), and >5,000-fold selectivity over p38γ and p38δ.